AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Americans are Flying, Airline Stocks are Not
Motley Fool Money
Eli Lilly's Acquisition of Morphic Holding
Exploring Eli Lilly's $3.2 billion acquisition of Morphic Holding as a strategic move to diversify and expand into chronic disease therapies, particularly focusing on inflammatory bowel diseases. The chapter also highlights Lilly's past acquisitions and their approach to organic growth and diversification in the pharmaceutical industry.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode